Want to see SLQT full AI Analyst Report?
SLQT Stock Chart & Stats
$0.55
$0.02(2.10%)
At close: 4:00 PM EDT
$0.55
$0.02(2.10%)
Day’s Range― - ―
52-Week Range$0.31 - $2.22
Previous CloseN/A
Volume334.21K
Average Volume (3M)1.03M
Market Cap
$56.84M
Enterprise Value$835.20M
Total Cash (Recent Filing)$20.72M
Total Debt (Recent Filing)$398.02M
Price to Earnings (P/E)―
Beta1.63
Next Earnings
Nov 04, 2026EPS Estimate
-0.32Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding179,261,800
10 Day Avg. Volume1,268,265
30 Day Avg. Volume1,028,652
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)0.24
Price to Sales (P/S)0.10
P/FCF Ratio5.73
Enterprise Value/Market Cap14.69
Enterprise Value/Revenue0.52
Enterprise Value/Gross Profit1.45
Enterprise Value/Ebitda6.04
Forecast
1Y Price Target
$2.17Price Target Upside293.94% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.13
Revenue Forecast (FY)$1.74B
Bulls Say, Bears Say
Bulls Say
Debt ReductionDebt reduction from roughly $714–732M in 2023–2024 to about $48M in 2026 materially lowers financial risk and should reduce refinancing pressure. The stronger equity base and lower debt-to-equity ratio give SelectQuote more flexibility to absorb volatility and fund operations.
Healthcare Services ProfitabilityHealthcare Services is showing a meaningful profitability inflection, with a strong exit EBITDA run rate and expected margin expansion. If these efficiency gains persist, the segment can become a more durable contributor to consolidated earnings and cash generation over the next several quarters.
Senior Segment MarginsFour consecutive years of mid-20% Senior margins indicate resilience in SelectQuote’s agent-led, technology-enabled distribution model. This sustained profitability provides an important earnings foundation and suggests the company can remain economically attractive even when policy volumes fluctuate.
Bears Say
FY27 Revenue PressureManagement’s FY27 revenue outlook implies a substantial contraction after FY26 growth, limiting near-term operating leverage and making earnings improvement more dependent on cost reductions. Lower policy volumes and industry headwinds could also weaken the scale advantages of the distribution platform.
High Funding CostA roughly 12% cost on approximately $800M of debt and preferred capital creates a persistent cash burden and reduces the benefit of operating gains. High funding costs constrain reinvestment, limit financial flexibility, and make deleveraging important for sustaining future profitability.
Uneven Cash ConversionThe multi-year pattern of negative operating and free cash flow shows that reported profitability has not consistently translated into cash generation. Although 2026 improved, uneven conversion raises questions about earnings durability and could restrict the company’s ability to reduce funding costs internally.
SelectQuote News
SLQT FAQ
What was SelectQuote’s price range in the past 12 months?
SelectQuote lowest stock price was $0.31 and its highest was $2.22 in the past 12 months.
What is SelectQuote’s market cap?
SelectQuote’s market cap is $56.84M.
When is SelectQuote’s upcoming earnings report date?
SelectQuote’s upcoming earnings report date is Nov 04, 2026 which is in 15 days.
How were SelectQuote’s earnings last quarter?
SelectQuote released its earnings results on Aug 25, 2026. The company reported -$0.19 earnings per share for the quarter, missing the consensus estimate of -$0.165 by -$0.025.
Is SelectQuote overvalued?
According to Wall Street analysts SelectQuote’s price is currently Undervalued.
Does SelectQuote pay dividends?
SelectQuote does not currently pay dividends.
What is SelectQuote’s EPS estimate?
SelectQuote’s EPS estimate is -0.32.
How many shares outstanding does SelectQuote have?
SelectQuote has 179,261,800 shares outstanding.
What happened to SelectQuote’s price movement after its last earnings report?
SelectQuote reported an EPS of -$0.19 in its last earnings report, missing expectations of -$0.165. Following the earnings report the stock price went down -29.381%.
Which hedge fund is a major shareholder of SelectQuote?
Currently, no hedge funds are holding shares in SLQT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SelectQuote Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.17 (293.94% Upside)
$2.17 (293.94% Upside)
Hedge Fund Trend
Increased
By 68.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 0.7%
Last 30 Days ▼ 0.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-82.77%
12-Months-Change
Fundamentals
Return on Equity
10.03%
Trailing 12-Months
Asset Growth
2.40%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
SelectQuote
SelectQuote, Inc. operates as a tech-driven, direct-to-consumer marketplace, offering a wide spectrum of insurance products to individuals throughout the United States. These policies are underwritten by a variety of insurance carriers. The company structures its operations across three core divisions: Senior, Life, and Auto & Home. Within its Senior segment, SelectQuote provides access to a comprehensive suite of health policies, including Medicare Advantage, Medicare Supplement, and Medicare Part D plans. This segment also features ancillary coverages such as prescription drug plans, dental, vision, and hearing benefits. The Life division concentrates on term life insurance offerings, while the Auto & Home segment delivers personal automobile, homeowners', and general casualty insurance solutions. Established in 1999, SelectQuote, Inc. is headquartered in Overland Park, Kansas.
SLQT Company Deck
SLQT Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a balanced picture: strong execution on profitability and cash flow (notably a $44M year-over-year operating cash flow improvement, Healthcare Services inflection to a near $50M annual EBITDA run rate, and >$30M of identified cost savings) contrasted with meaningful top-line headwinds (guidance implying ~14% revenue decline in 2027), ongoing Medicare Advantage market volatility, IRA-related revenue pressure, and a relatively high-cost capital structure (~$800M at ~12%). Management is prioritizing cash generation and deleveraging over growth in fiscal 2027, which supports a constructive longer-term view but leaves notable near-term revenue and capital risks.View all SLQT earnings summariesSLQT Stock 12 Month Forecast
Average Price Target
$2.17
▲(293.94% Upside)
Technical Analysis
Ownership Overview
30.16% Insiders
6.98% Mutual Funds
0.60% Other Institutional Investors
57.59% Public Companies and
Individual Investors